This contemporary, international, evidence-informed guidance aims to achieve the greatest
good for the greatest number of people with familial hypercholesterolaemia (FH) across …

Abstract Cardiovascular disease complicates 1–4% of pregnancies—with a higher
prevalence when including hypertensive disorders—and is the leading cause of maternal …

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on
the Management of Blood Cholesterol: Executive Summary: A Report of the American …

The recommendations listed in the present guideline are, whenever possible, evidence
based. An initial extensive evidence review, which included literature derived from research …

not override in any way whatsoever the individual responsibility of health professionals to
make appropriate and accurate decisions in consideration of each patient's health condition …

Cardiovascular disease complicating pregnancy is rising in prevalence secondary to
advanced maternal age, cardiovascular risk factors, and the successful management of …

Abstract The Canadian Consensus Working Group has updated its evaluation of the
literature pertaining to statin intolerance and adverse effects. This overview introduces a …

For years, it has been recognized that the incidence of coronary heart disease (CHD) in
women lags behind that of men by≈ 10 years, 7 thus generating hypotheses that …

Background Preeclampsia complicates approximately 3–5% of pregnancies and remains a
major cause of maternal and neonatal morbidity and mortality. It shares pathogenic …

Optimal care for familial hypercholesterolaemia (FH) requires patient-centred management,
multidisciplinary teamwork, involvement of primary care practitioners, patient networks …